Correction to: Prevalence of tumour-infiltrating CD103
+
cells identifies therapeutic-sensitive prostate cancer with poor clinical outcome
Br J Cancer
.
2023 May;128(9):1788-1789.
doi: 10.1038/s41416-023-02211-3.
Authors
Quan Zhou
#
1
2
,
Yuxi Ou
#
1
2
,
Xiyu Dai
#
1
2
,
Xinan Chen
#
1
2
,
Siqi Wu
1
2
,
Wensun Chen
1
2
,
Mengbo Hu
1
2
,
Chen Yang
3
4
5
,
Limin Zhang
6
7
8
,
Haowen Jiang
9
10
11
12
Affiliations
1
Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
2
Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China.
3
Department of Urology, Huashan Hospital, Fudan University, Shanghai, China. yangc_huashan@163.com.
4
Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China. yangc_huashan@163.com.
5
National Clinical Research Center for Aging and Medicine, Fudan University, Shanghai, China. yangc_huashan@163.com.
6
Department of Urology, Huashan Hospital, Fudan University, Shanghai, China. zhalim@fudan.edu.cn.
7
Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China. zhalim@fudan.edu.cn.
8
National Clinical Research Center for Aging and Medicine, Fudan University, Shanghai, China. zhalim@fudan.edu.cn.
9
Department of Urology, Huashan Hospital, Fudan University, Shanghai, China. haowj_sh@fudan.edu.cn.
10
Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China. haowj_sh@fudan.edu.cn.
11
National Clinical Research Center for Aging and Medicine, Fudan University, Shanghai, China. haowj_sh@fudan.edu.cn.
12
Department of Urology, Jing'an District Central Hospital, Fudan University, Shanghai, China. haowj_sh@fudan.edu.cn.
#
Contributed equally.
PMID:
36941407
PMCID:
PMC10133239
DOI:
10.1038/s41416-023-02211-3
No abstract available
Publication types
Published Erratum